| Date | Time | Source | Headline | Symbol | Company |
| 07/02/2024 | 11:19AM | iHub Newswire | FeaturedBNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth | | |
| 08/12/2008 | 11:58AM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 08/08/2008 | 11:44AM | Edgar (US Regulatory) | Forest Laboratories Inc - Quarterly Report (10-Q) | NYSE:FRX | Forest Road Acquisition Corp |
| 08/08/2008 | 6:01AM | Edgar (US Regulatory) | Forest Laboratories Inc - Amended Statement of Ownership (SC 13G/A) | NYSE:FRX | Forest Road Acquisition Corp |
| 08/04/2008 | 4:04PM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 07/30/2008 | 1:30PM | PR Newswire (US) | New Data Highlight Positive Results of Namenda(R) (memantine HCl) Once-Daily Extended-Release Formulation | NYSE:FRX | Forest Road Acquisition Corp |
| 07/24/2008 | 11:08AM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 07/23/2008 | 9:58AM | Edgar (US Regulatory) | Forest Laboratories Inc - Confidential Treatment Order (CT ORDER) | NYSE:FRX | Forest Road Acquisition Corp |
| 07/22/2008 | 4:08PM | Edgar (US Regulatory) | Forest Laboratories Inc - Current report filing (8-K) | NYSE:FRX | Forest Road Acquisition Corp |
| 07/22/2008 | 8:00AM | PR Newswire (US) | Forest Laboratories, Inc. Reports Fiscal First Quarter 2009 Earnings Per Share of $0.79, Including $0.08 per Share Charge for Ag | NYSE:FRX | Forest Road Acquisition Corp |
| 07/01/2008 | 1:26PM | Edgar (US Regulatory) | Forest Laboratories Inc - Proxy Statement (definitive) (DEF 14A) | NYSE:FRX | Forest Road Acquisition Corp |
| 06/30/2008 | 5:42PM | PR Newswire (US) | Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2009 First Quarter Earnings | NYSE:FRX | Forest Road Acquisition Corp |
| 06/20/2008 | 5:26PM | Edgar (US Regulatory) | Forest Laboratories Inc - Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A) | NYSE:FRX | Forest Road Acquisition Corp |
| 06/19/2008 | 7:50AM | PR Newswire (US) | Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated S | NYSE:FRX | Forest Road Acquisition Corp |
| 06/02/2008 | 4:35PM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 05/30/2008 | 12:28PM | Edgar (US Regulatory) | Forest Laboratories Inc - Annual Report (10-K) | NYSE:FRX | Forest Road Acquisition Corp |
| 05/20/2008 | 6:30PM | PR Newswire (US) | Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Result | NYSE:FRX | Forest Road Acquisition Corp |
| 05/20/2008 | 11:30AM | PR Newswire (US) | Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic f | NYSE:FRX | |
| 05/16/2008 | 3:54PM | PR Newswire (US) | /C O R R E C T I O N -- Forest Laboratories, Inc./ | NYSE:FRX | Forest Road Acquisition Corp |
| 05/15/2008 | 1:22PM | PR Newswire (US) | Forest Laboratories, Inc. and Laboratorios Almirall, S.A. to Host Webcast to Discuss Aclidinium Bromide Data Presentations at th | NYSE:FRX | Forest Road Acquisition Corp |
| 05/12/2008 | 8:45AM | PR Newswire (US) | Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the AZOR Co-Promotion Agreement | NYSE:FRX | Forest Road Acquisition Corp |
| 05/07/2008 | 12:00PM | PR Newswire (US) | Study Demonstrates Lexapro(R) Significantly Improves Depression Symptoms in Adolescents | NYSE:FRX | Forest Road Acquisition Corp |
| 04/16/2008 | 11:31AM | Edgar (US Regulatory) | Forest Laboratories Inc - Current report filing (8-K) | NYSE:FRX | Forest Road Acquisition Corp |
| 04/15/2008 | 8:50AM | PR Newswire (US) | Forest Laboratories, Inc. Reports Fiscal Year 2008 Fourth Quarter Reported EPS of $0.55 Including $0.35 Per Share Charge for Lic | NYSE:FRX | Forest Road Acquisition Corp |
| 04/10/2008 | 4:20PM | Edgar (US Regulatory) | Forest Laboratories Inc - Amended Annual Report (10-K/A) | NYSE:FRX | Forest Road Acquisition Corp |
| 04/08/2008 | 3:22PM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 04/07/2008 | 1:33PM | PR Newswire (US) | Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2008 Fourth Quarter Earnings | NYSE:FRX | Forest Road Acquisition Corp |
| 04/01/2008 | 5:26PM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 03/20/2008 | 10:16AM | Edgar (US Regulatory) | Forest Laboratories Inc - Current report filing (8-K) | NYSE:FRX | Forest Road Acquisition Corp |
| 03/19/2008 | 8:12AM | PR Newswire (US) | Forest Laboratories Announces Resignation of Ivan Gergel, MD | NYSE:FRX | Forest Road Acquisition Corp |